Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Otgontuya, Dugee ^a   Oum, Sophal ^b   Buckley, Brian S ^c   Bonita, Ruth ^d  

^a Ministry of Health   (Mongolia)

^b UNIVERSITY OF HEALTH SCIENCES   (Cambodia)

^c UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ASIA; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASES; DEVELOPING COUNTRY; FEMALE; HEALTH SURVEY; HUMAN; INCOME; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; PROCEDURES; RISK FACTOR; SOCIAL CLASS; WORLD HEALTH ORGANIZATION;

ADULT; ASIA; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; DEVELOPING COUNTRIES; FEMALE; HUMANS; INCOME; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SOCIAL CLASS; WORLD HEALTH ORGANIZATION;

EID: 84879108657     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-539     Document Type: Article

References (40)

1. Reducing the growing burden of cardiovascular disease in the developing world. Graziano TA, Health Aff 2007 26 1 13 24 10.1377/hlthaff.26.1.13
2. World Health Organization, Noncommunicable disease and poverty. The need for pro-poor strategies in the Western Pacific Region Manila: World Health Organization, Western Pacific Region 2006
3. Individual-based primary prevention of cardiovascular disease in Cambodia and Mongolia: early identification and management of hypertension and diabetes mellitus. Otgontuya D, Oum S, Palam E, Rani M, Buckley BS, BMC Public Health 2012 12 254 10.1186/1471-2458-12-254 22471424
4. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Capewell S, Beaglehole R, Seddon M, McMurray J, et al. Circulation 2000 102 13 1511 1516 10.1161/01.CIR.102.13. 1511 11004141
5. Explaining the decrease in UD deaths from coronary disease, 1980-200. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, N Engl J Med 2007 356 2388 2398 10.1056/NEJMsa053935 17554120 (Pubitemid 46883773)
6. Kelly MP, Capewell S, Relative contributions of changes in risk factors and treatment to the reduction in coronary heart disease mortality (Briefing Paper) London: NHS Health Development Agency (Briefing Paper) 2004
7. Explaining the decline in coronary heart disease mortality in Italy between 1980 and 2000. Palmieri L, Bennett K, Giampaoli S, Capewell S, Am J Public Health 2010 100 4 684 692 10.2105/AJPH.2008.147173 19608958
8. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Unal B, Critchley JA, Capewell S, Circulation 2004 109 9 1101 1107 10.1161/01.CIR.0000118498.35499.B2 14993137 (Pubitemid 38332613)
9. Thirty-five-year trends in cardiovascular risk factors in Finland. Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Mannisto S, Sundvall J, et al. Int J Epidemiol 2010 39 504 518 10.1093/ije/dyp330 19959603
10. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings. Mendis S, Lindholm LH, Anderson SG, Alwan A, Koju R, Onwubere BJC, et al. J Clin Epidemiol 2011 10.1016/j.jclinepi.2011.02.001
11. Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles. Ndindjock R, Gedeon J, Mendis S, Paccaud F, Bovet P, Bull World Health Organ 2011 89 286 295 10.2471/BLT.10.082370 21479093
12. World Health Organization, Prevention of cardiovascular disease: Guidelines for assessment and management of cardiovascular risk Geneva: World Health Organization 2007
13. The Framingham Heart Study's Impact on Global Risk Assessment. Bitton A, Gaziano T, Prog Cardiovasc Dis 2010 53 68 78 10.1016/j.pcad.2010.04.001 20620429
14. A general cardiovascular risk profile: the Framingham Study. Kannel WB, McGee D, Gordon T, Am J Cardiol 1976 38 46 51 10.1016/0002-9149(76)90061-8 132862
15. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Assmann G, Cullen P, Schulte H, Circulation 2002 105 310 315 10.1161/hc0302.102575 11804985 (Pubitemid 34106178)
16. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Eur Heart J 2003 24 987 1003 10.1016/S0195-668X(03)00114-3 12788299 (Pubitemid 36712275)
17. Primary and subsequent coronary risk appraisal: new results from The Framingham Study. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, et al. Am Heart J 2000 139 272 281 10650300 (Pubitemid 30090804)
18. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. BMJ 2007 335 136 10.1136/bmj.39261.471806.55 17615182 (Pubitemid 47172233)
19. Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Jones AF, Walker J, Jewkes C, Game FL, Bartlett WA, Marshall T, et al. Heart 2001 85 37 43 10.1136/heart.85.1.37 11119458 (Pubitemid 32973402)
20. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K, Eur Heart J 1998 19 1434 1503 10.1053/euhj.1998.1243 9820987 (Pubitemid 28470470)
21. Joint British Recommendations on prevention of coronary heart disease in clinical practice. Wood D, Durrington P, Poulter N, Heart 1998 80 Supplement 2 1 S29 10193438
22. Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check? Ferket BS, Colkesen EB, Visser JJ, et al. Arch Intern Med 2010 170 27 40 10.1001/archinternmed.2009.434 20065196
23. Cardiovascular risk assessment-from individual risk prediction to estimation of global risk and change in risk in the population. Batsis JA, Lopez-Jimenez F, BMC Med 2010 8 29 10.1186/1741-7015-8-29 20500815
24. Health and health-care systems in southeast Asia: diversity and transitions. Chongsuvivatwong V, Phua KH, Yap MT, Pocock NS, Hashim JH, Chhem R, et al. Lancet 2011 377 429 437 10.1016/S0140-6736(10)61507-3 21269685
25. World Health Organization, Western Pacific Country Health Information Profiles Manila: World Health Organization, Western Pacific Region 2010
26. World Health Organization, World Health Statistics 2011 Geneva: World Health Organization 2011
27. World Bank Country Data http://databank.worldbank.org/data/views/reports/ tableview.aspx
28. Disease Control Division, Malaysia NCD Surveillance 2006: Non communicable disease risk factors in Malaysia Kuala Lumpur: Ministry of Health Malaysia 2006
29. Oum S, Prak PR, Khuon EM, Mey V, Aim S, Buonchan Y, et al. Prevalence of non-communicable disease risk factors in Cambodia: STEPS survey country report, September 2010 Phnom Penh: University of Health Sciences and the Ministry of Health 2010
30. Public Health Institute, Mongolian Steps Survey on the prevalence of noncommunicable disease and injury risk factors-2009 Mongolia: Ministry of Health 2009
31. World Health Organization, Mongolian STEPS Survey on the Prevalence of Noncommunicable Disease Risk Factors 2006 Geneva: World Health Organization 2007
32. World Health Organization, Prevention of cardiovascular disease. Pocket Guidelines for Assessment and Management of Cardiovascular Risk Geneva: World Health Organization 2007
33. Laboratory-based versus non-laboratory based method for assessment of cardiovascular disease risk: the NHANES I follow-up study. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM, Lancet 2008 371 923 931 10.1016/S0140-6736(08)60418-3 18342687 (Pubitemid 351375276)
34. High heart rate: a cardiovascular risk factor? Cook S, Togni M, Schaub MC, Wenawesen P, Hess OM, Eur Heart J 2006 27 2387 2393 10.1093/eurheartj/ehl259 17000632 (Pubitemid 44522142)
35. Resting heart rate in cardiovascular disease. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, et al. J Am Coll Cardiol 2007 50 823 830 10.1016/j.jacc.2007.04.079 17719466 (Pubitemid 47277500)
36. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Kristal-Boneh E, Silber H, Harari G, Froom P, Eur Heart J 2000 21 116 124 10.1053/euhj.1999.1741 10637085 (Pubitemid 30072626)
37. Cardiovascular risk scores do not account for the effect of treatment: a review. Liew SM, Doust J, Glasziou P, Heart 2011 97 9 689 697 10.1136/hrt.2010.220442 21474616
38. Revised WHO Discusson Paper, A Comprehensive Global Monitoring Framework, Including Indicators, and a Set of Voluntary Global Targets for the Prevention and Control of Non-Communicable Diseases. 25 July 2012 Geneva: World Health Organization 2012
39. Cardiovascular Round Table Task Force. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology. Graham IM, Stewart M, Hertog MG, Eur J Cardiovasc Prev Rehabil 2006 13 839 845 10.1097/01.hjr.0000219112. 02544.24 17001227 (Pubitemid 44454860)
40. Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions. Sposito AC, Ramires JAF, Jukema JW, et al. Curr Med Res Opin 2009 25 1171 1178 10.1185/03007990902846423 19323611